Myriad to sell prenatal health business to Labcorp (MYGN:NASDAQ)
· seekingalpha.com
Myriad Genetics (MYGN) stock jumps as the company sells its Prenatal Health testing unit to Labcorp in an all-cash deal worth more than $210M. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...